Cutler Group LP Bridge Bio Pharma, Inc. Put Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	SELL	$16.89 - $35.01 $1,689 - $3,501	-100 Reduced 9.09%	1,000 $9,000
Q2 2023 Jul 18, 2023	SELL	$13.29 - $18.01 $268,458 - $363,802	-20,200 Reduced 94.84%	1,100 $0
Q1 2023 May 01, 2023	BUY	$7.17 - $18.55 $152,721 - $395,115	21,300 New	21,300 $3,000
Q3 2022 Oct 25, 2022	BUY	$7.94 - $12.36 $7,940 - $12,360	1,000 Added 100.0%	2,000 $1,000
Q2 2022 Aug 04, 2022	SELL	$5.21 - $12.14 $79,713 - $185,742	-15,300 Reduced 93.87%	1,000 $1,000

Q1 2022 Apr 14, 2022	SELL	$7.34 - $17.16 $853,642 - $2 Million	-116,300 Reduced 87.71%	16,300 $137,000
Q4 2021 Jan 18, 2022	BUY	$11.38 - $53.41 $1.48 Million - $6.96 Million	130,400 Added 5927.27%	132,600 $771,000
Q1 2021 Apr 26, 2021	SELL	$55.47 - $72.35 $432,666 - $564,330	-7,800 Reduced 78.0%	2,200 $1,000
Q1 2020 May 07, 2020	BUY	$16.11 - $36.23 $161,100 - $362,299	10,000 New	10,000 $53,000

285

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.71B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.